Probing the Effect of the Non-Active-Site Mutation Y229W in New Delhi Metallo-β-lactamase-1 by Site-Directed Mutagenesis, Kinetic Studies, and Molecular Dynamics Simulations
暂无分享,去创建一个
Hui Chen | Yun Shi | Xingzhen Lao | Xiangdong Gao | Heng Zheng | Wenbing Yao | Xiangdong Gao | Xingzhen Lao | Heng Zheng | W. Yao | Jiao Chen | Feng Hu | Yun Shi | Hui Chen | Jiao Chen | F. Hu
[1] Hua Guo,et al. Characterization of purified New Delhi metallo-β-lactamase-1. , 2011, Biochemistry.
[2] Ju-Guang Han,et al. Probing ligand-binding modes and binding mechanisms of benzoxazole-based amide inhibitors with soluble epoxide hydrolase by molecular docking and molecular dynamics simulation. , 2012, The journal of physical chemistry. B.
[3] Jürgen Pleiss,et al. Insight into the mechanism of the IMP-1 metallo-beta-lactamase by molecular dynamics simulations. , 2003, Protein engineering.
[4] Jürgen Pleiss,et al. Insight into the mechanism of the IMP-1 metallo-β-lactamase by molecular dynamics simulations , 2003 .
[5] G. Bou,et al. Beta-lactamase inhibitors: the story so far. , 2009, Current medicinal chemistry.
[6] N. Strynadka,et al. New Delhi metallo-β-lactamase: structural insights into β-lactam recognition and inhibition. , 2012, Journal of the American Chemical Society.
[7] Yong Chen,et al. A quantum mechanics/molecular mechanics study on the hydrolysis mechanism of New Delhi metallo-β-lactamase-1 , 2013, Journal of Computer-Aided Molecular Design.
[8] Molecular dynamics and free energy studies on the carboxypeptidases complexed with peptide/small molecular inhibitor: mechanism for drug resistance. , 2012, Insect biochemistry and molecular biology.
[10] J. Frère,et al. Biochemical Characterization of the Pseudomonas aeruginosa 101/1477 Metallo-β-Lactamase IMP-1 Produced byEscherichia coli , 1999, Antimicrobial Agents and Chemotherapy.
[11] Liam J. Worrall,et al. New Delhi Metallo-Beta-Lactamase: Structural Insights into Beta-Lactam Recognition and Inhibition , 2012 .
[12] P. Kollman,et al. A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .
[13] H. Giamarellou,et al. Multidrug-Resistant Gram-Negative Infections are the Treatment Options? , 2009 .
[14] J. Frère,et al. Standard numbering scheme for class B beta-lactamases. , 2001, Antimicrobial agents and chemotherapy.
[15] Hwangseo Park,et al. Hybrid QM/MM and DFT investigations of the catalytic mechanism and inhibition of the dinuclear zinc metallo-beta-lactamase CcrA from Bacteroides fragilis. , 2005, Journal of the American Chemical Society.
[16] M. Sparta,et al. The Role of the Flexible L43-S54 Protein Loop in the CcrA Metallo-β-lactamase in Binding Structurally Dissimilar β-Lactam Antibiotics. , 2013, Journal of chemical theory and computation.
[17] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[18] R. Schmid,et al. Modeling domino effects in enzymes: molecular basis of the substrate specificity of the bacterial metallo-beta-lactamases IMP-1 and IMP-6. , 2003, Biochemistry.
[19] A. Buschiazzo,et al. Evidence of adaptability in metal coordination geometry and active-site loop conformation among B1 metallo-beta-lactamases . , 2010, Biochemistry.
[20] Timothy R. Walsh,et al. Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India , 2009, Antimicrobial Agents and Chemotherapy.
[21] D. Wareham,et al. A Novel Variant, NDM-5, of the New Delhi Metallo-β-Lactamase in a Multidrug-Resistant Escherichia coli ST648 Isolate Recovered from a Patient in the United Kingdom , 2011, Antimicrobial Agents and Chemotherapy.
[22] Youngchang Kim,et al. NDM‐1, the ultimate promiscuous enzyme: substrate recognition and catalytic mechanism , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] Yuan-Ping Pang,et al. Novel Zinc Protein Molecular Dynamics Simulations: Steps Toward Antiangiogenesis for Cancer Treatment , 1999 .
[24] N. Woodford,et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.
[25] G. Ciccotti,et al. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .
[26] C. Bebrone. Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. , 2007, Biochemical pharmacology.
[27] Cheng Luo,et al. Molecular Basis of NDM-1, a New Antibiotic Resistance Determinant , 2011, PloS one.
[28] Wanzhi Huang,et al. Analysis of the Functional Contributions of Asn233 in Metallo-β-Lactamase IMP-1 , 2011, Antimicrobial Agents and Chemotherapy.
[29] S. Kingsmore,et al. Molecular dynamic simulations of the metallo-beta-lactamase from Bacteroides fragilis in the presence and absence of a tight-binding inhibitor , 2009, Journal of molecular modeling.
[30] Hui Chen,et al. Inhibitor Discovery of Full-Length New Delhi Metallo-β-Lactamase-1 (NDM-1) , 2013, PloS one.
[31] P. Nordmann,et al. NDM-4 Metallo-β-Lactamase with Increased Carbapenemase Activity from Escherichia coli , 2012, Antimicrobial Agents and Chemotherapy.
[32] Moreno Galleni,et al. Standard Numbering Scheme for Class B β-Lactamases , 2001, Antimicrobial Agents and Chemotherapy.
[33] T. Palzkill. Metallo‐β‐lactamase structure and function , 2013, Annals of the New York Academy of Sciences.
[34] Quan Hao,et al. Crystal structure of NDM‐1 reveals a common β‐lactam hydrolysis mechanism , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[36] L. Hsu,et al. World Health Day 2011: combating antimicrobial resistance. , 2011, Singapore medical journal.
[37] Honggang Zhou,et al. A structural view of the antibiotic degradation enzyme NDM-1 from a superbug , 2011, Protein & Cell.
[38] Michael W Crowder,et al. Mechanistic and spectroscopic studies of metallo-β-lactamase NDM-1. , 2012, Biochemistry.
[39] B. Brooks,et al. An analysis of the accuracy of Langevin and molecular dynamics algorithms , 1988 .
[40] G. Bou,et al. Beta-lactamase inhibitors: the story so far. , 2009, Current medicinal chemistry.
[41] J. Frère,et al. Role of Cys221 and Asn116 in the zinc-binding sites of the Aeromonas hydrophila metallo-β-lactamase , 2003, Cellular and Molecular Life Sciences CMLS.